FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.573
-0.007 (-1.14%)
At close: Jan 17, 2025, 4:00 PM
0.572
0.00 (-0.07%)
After-hours: Jan 17, 2025, 7:59 PM EST
FibroGen Employees
FibroGen had 486 employees as of December 31, 2023. The number of employees decreased by 106 or -17.91% compared to the previous year.
Employees
486
Change (1Y)
-106
Growth (1Y)
-17.91%
Revenue / Employee
$370,401
Profits / Employee
-$250,603
Market Cap
57.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
FGEN News
- 5 weeks ago - FibroGen Appoints David DeLucia as Chief Financial Officer - GlobeNewsWire
- 2 months ago - FibroGen, Inc. (FGEN) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - FibroGen Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - FibroGen to Report Third Quarter 2024 Financial Results - GlobeNewsWire
- 5 months ago - FibroGen, Inc. (FGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program - Benzinga
- 6 months ago - FibroGen to Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 8 months ago - FibroGen: Two New In-Licensed Oncology Drugs To Carry It Forward - Seeking Alpha